Some ingestible cannabis products that Health Canada considers noncompliant with federal rules still appear to be widely available in parts of the country, almost a year after the regulator asked companies to stop selling them to consumers because of concerns about overconsumption of THC.
The wide availability of these products on store shelves in some provinces has thrown the market for ingestibles into turmoil, making it harder for producers committed to regulatory compliance to know what is kosher and what isn’t – this at a time when companies are struggling financially.
ADVERTISEMENT
Ingestible products, such as lozenges and chewable extracts, have been increasingly popular among Canadian consumers.
Experts say their continued availability in the wake of Health Canada’s call for a sales halt in early 2023 boils down to multiple factors:
A persistent regulatory gray area between what constitutes an “edible” or an “extract.” A struggling
Read full article on Marijuana Business Daily